View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0910-0659
ICR Reference No:
201302-0910-001
Status:
Historical Inactive
Previous ICR Reference No:
201002-0910-005
Agency/Subagency:
HHS/FDA
Agency Tracking No:
18061
Title:
Animal Drug User Fee Amendments of 2008 (ADUFA 2008)--21 U.S.C. 360b(l)
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Improperly submitted and continue
Conclusion Date:
04/10/2013
Retrieve Notice of Action (NOA)
Date Received in OIRA:
02/04/2013
Terms of Clearance:
In accordance with 5 CFR 1320, this ICR is improperly submitted. The burden data entered into ROCIS does not match the Supporting Statement. Please correct this and resubmit to OMB when ready.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
03/31/2013
36 Months From Approved
11/30/2013
Responses
320
0
320
Time Burden (Hours)
15,680
0
15,680
Cost Burden (Dollars)
107,880
0
107,880
Abstract:
This information collection requires that sponsors of each new animal drug that contains an antimicrobial agent submit an annual report to FDA on the amount of each antimicrobial active ingredient in the drug that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product. Its purpose is to ensure that the FDA has the necessary information to examine safety concerns related to the use of antibiotics in food-producing animals. With this revision of the information collection, FDA is adding a voluntary e-form FDA 3744a that will enable sponsors to submit electronically and capture all information as mandated by Section 105 of the Animal Drug User Fee Amendments of 2008.
Authorizing Statute(s):
US Code:
21 USC 360b
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
77 FR 2302
01/17/2012
30-day Notice:
Federal Register Citation:
Citation Date:
78 FR 5463
01/25/2013
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
5
IC Title
Form No.
Form Name
Annual Reports for Sponsors with Active Applications (e-form FDA 3744a)
FDA 3744a
Electronic Form FDA 3744 Antimicrobial Animal Drug Distribution Report for ADUFA Section 105
Annual Reports for Sponsors with Inactive Applications (e-form FDA 3744a)
FDA 3744a
Electronic Form FDA 3744 Antimicrobial Animal Drug Distribution Report for ADUFA Section 105
Annual Reports for Sponsors with Inactive Applications (paper submission form FDA 3744)
FDA 3744
Antimicrobial Animal Drug Distribution Report
Requirement for All Applicants to Include Separate Information for Each Month in Their Records
FDA 3744
Antimicrobial Animal Drug Distribution Report
Submission of Annual Reports for Sponsors with Active Applications (paper submission form FDA 3744)
FDA 3744
Antimicrobial Animal Drug Distribution Report
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Changing Forms
Short Statement:
FDA is adding e-form FDA 3744a, an electronic format of the already approved paper form FDA 3744.
Annual Cost to Federal Government:
$355,469
Does this IC contain surveys, censuses, or employ statistical methods?
No
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
JonnaLynn Capezzuto 301 827-4659 jonnalynn.capezzuto@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
02/04/2013
An official website of the United States government
The .gov means it's official.
The site is secure.
